Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

NCT03710252

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)

NCT01405937

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

NCT02640547

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

NCT00704405

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis

NCT02517528

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV), +15 more
Locations: Not specified

View Trial Details

Completed

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

NCT02105467

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations: Not specified

View Trial Details

Completed

Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination

NCT03490097

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +21 more
Locations: Kobri El koba Armed Forces Hospital Cairo, Egypt

View Trial Details

Completed

A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)

NCT02666352

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

NCT02804386

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Ojha, Duhs Karachi, Sindh, Pakistan

View Trial Details

Completed

Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)

NCT01974687

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details